Clinical Trials Logo

Filter by:
NCT ID: NCT03585920 Completed - Appetitive Behavior Clinical Trials

The Influence of Fat Perception on Satiety From Consumption of Reduced Fat Snacks

Start date: July 2, 2018
Phase: N/A
Study type: Interventional

The present study aims to investigate the effect of fat level and fat type of a snack on self-reported satiety and associated biomarkers. The relevant individual differences will also be investigated.

NCT ID: NCT03584191 Completed - Obesity Clinical Trials

Awareness, Care & Treatment In Obesity Management - An International Observation

ACTION-IO
Start date: June 4, 2018
Phase:
Study type: Observational

The purpose of this survey is to collect the data on perceptions, behaviours and awareness related to obesity and obesity management for People with Obesity (PwO) and Health Care Professionals (HCP) treating obesity. Data will be collected via online surveys among each of the respondent groups. The surveys are expected to take approximately 25 minutes to complete and will be unique for PwO and HCP. As a cross-sectional study, there will be no treatment of patients.

NCT ID: NCT03583697 Completed - Achondroplasia Clinical Trials

A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia

Start date: June 13, 2018
Phase: Phase 2
Study type: Interventional

Study 111-206 is a Phase 2 randomized, double-blind, placebo-controlled clinical trial of BMN 111 in infants and young children with a diagnosis of achondroplasia.

NCT ID: NCT03583489 Completed - Clinical trials for Postoperative Nausea and Vomiting

Study of APD421 With and Without Ondansetron

Start date: July 17, 2018
Phase: Phase 1
Study type: Interventional

Collection of pharmacokinetic and electrocardiograph data from healthy volunteers given APD421 +/- ondansetron

NCT ID: NCT03582826 Completed - Clinical trials for Nutritional and Metabolic Diseases

Microbial Basis of Systemic Malodor and "People Allergic To Me" Conditions

PATM
Start date: June 16, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to identify microbial signatures associated with remission and recurrence of idiopathic malodor and PATM conditions.

NCT ID: NCT03582098 Completed - Clinical trials for Chronic Lymphocytic Leukaemia

Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland

RETRO-idel
Start date: September 12, 2018
Phase:
Study type: Observational

The primary objective of this study is to evaluate the effectiveness of idelalisib and rituximab in adults with chronic lymphocytic leukaemia (CLL) in a real world setting

NCT ID: NCT03582072 Completed - Clinical trials for Prescribing, Off-Label

CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018

Start date: February 27, 2018
Phase: N/A
Study type: Interventional

This trial aims to reduce unnecessary prescription of antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not improve patient health outcomes. The intervention is to send GPs a letter from the Chief Medical Officer (CMO) that gives feedback on their practice's prescribing levels. Specifically, GPs in practices whose prescribing has increase by more than 4% over the past year will receive a letter stating that "The great majority (80%) of practices in England reduced or stabilised their antibiotic prescribing rates in 2016/17. However, your practice is in the minority that have increased their prescribing by more than 4%." The letter will also contain a leaflet to help GPs discuss self-care advice with patients and some advice to use delayed prescriptions. The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group, following the receipt of the letter.

NCT ID: NCT03581812 Completed - Eating Behavior Clinical Trials

Snack Foods and Their Impact on Gastrointestinal Microbiology, Function and Symptoms

OptiGut
Start date: April 27, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of replacing usual snacks with alternative snack foods on gut health in a population of habitual snackers with low fibre intake.

NCT ID: NCT03580356 Completed - Clinical trials for Chronic Spontaneous Urticaria

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

Start date: October 20, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study was to establish efficacy and safety of ligelizumab in adolescent and adult subjects with CSU who remained symptomatic despite standard of care treatment by demonstrating better efficacy over omalizumab and over placebo. The study population consisted of 1,079 male and female subjects aged ≥ 12 years who were diagnosed with CSU and who remained symptomatic despite the use of H1-antihistamines. This was a multi-center, randomized, double-blind, active- and placebo-controlled, parallel-group study. There was a screening period of up to 28 days, a 52 week double-blind treatment period, and a 12 week post-treatment follow-up period.

NCT ID: NCT03580161 Completed - Clinical trials for Exposure to Medical Diagnostic Radiation

Simplification of Low Level Internal Dosimetry

SOLLID
Start date: June 30, 2018
Phase:
Study type: Observational

This is a pilot study with the primary aim being to identify the minimum number of scans and measurements necessary to determine accurately the absorbed radiation doses delivered from internal sources of radiation administered for diagnostic nuclear medicine procedures.